Phase II study of dose intensive temozolomide in elderly adults with newly diagnosed glioblastoma

Trial Profile

Phase II study of dose intensive temozolomide in elderly adults with newly diagnosed glioblastoma

Discontinued
Phase of Trial: Phase II

Latest Information Update: 21 Jan 2009

At a glance

  • Drugs Temozolomide (Primary)
  • Indications Glioblastoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Jan 2009 Planned end date (Jun 2007) added as reported by ClinicalTrials.gov.
    • 21 Jan 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 21 Jan 2009 Actual patient number (1) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top